BackgroundCheck.run
Search For

Lilly T Wong, 71Lakewood, CA

Lilly Wong Phones & Addresses

Lakewood, CA   

7998 W Zoe Ella Way, Peoria, AZ 85382   

13000 Watsonville Rd, Morgan Hill, CA 95037    408-7797896   

Gilbert, AZ   

San Francisco, CA   

Saint Louis, MO   

San Jose, CA   

Santa Clara, CA   

Maricopa, AZ   

Work

Company: Gowling WLG (Canada) LLP Address:

Mentions for Lilly T Wong

Career records & work history

Lawyers & Attorneys

Lilly Wong Photo 1

Lilly Wong - Lawyer

Office:
Gowling WLG (Canada) LLP
Specialties:
Banking, Secured Transactions, Real Estate, Corporate, Commercial, Creditors Rights, Insolvency
ISLN:
902645279
Admitted:
1981
University:
University of Alberta, B.A., 1976
Law School:
University of Toronto, LL.B., 1980

Medicine Doctors

Lilly Wong

Specialties:
Obstetrics & Gynecology
Work:
West Care Medical AssociatesWest Care Medical Obstetrics & Gynecology
50 W 77 St Frnt 1, New York, NY 10024
212-5796000 (phone) 212-5793687 (fax)
Site
Education:
Medical School
SUNY Downstate Medical Center College of Medicine
Graduated: 1998
Procedures:
Cesarean Section (C-Section), Myomectomy, Nutrition Therapy, Tubal Surgery, Vaccine Administration, Vaginal Delivery, Vaginal Repair
Conditions:
Breast Disorders, Genital HPV, Herpes Genitalis, Spontaneous Abortion, Abnormal Vaginal Bleeding, Candidiasis of Vulva and Vagina, Complicating Pregnancy or Childbirth, Conditions of Pregnancy and Delivery, Diabetes Mellitus Complicating Pregnancy or Birth, Endometriosis, Female Infertility, Follicular Cyst of the Ovary, Menopausal and Postmenopausal Disorders, Ovarian Dysfunction, Pelvic Inflammatory Disease (PID), Polycystic Ovarian Syndrome (PCOS), Pregnancy-Induced Hypertension, Premenstrual Syndrome (PMS), Uncomplicated or Low Risk Pregnancy and Delivery, Uterine Leiomyoma
Languages:
English
Description:
Dr. Wong graduated from the SUNY Downstate Medical Center College of Medicine in 1998. She works in New York, NY and specializes in Obstetrics & Gynecology. Dr. Wong is affiliated with Mount Sinai Roosevelt Hospital.

Lilly Wong resumes & CV records

Resumes

Lilly Wong Photo 40

Sr. Mortgage Loan Officer At Bank Of America Home Loans

Location:
Phoenix, Arizona Area
Industry:
Financial Services
Lilly Wong Photo 41

Lilly Wong

Lilly Wong Photo 42

Lilly Wong

Lilly Wong Photo 43

Lilly Wong

Lilly Wong Photo 44

Lilly Wong

Lilly Wong Photo 45

Sales Associate At Forever 21

Position:
Sales associate at Forever 21
Location:
Greater Los Angeles Area
Industry:
Apparel & Fashion
Work:
Forever 21
Sales associate
Lilly Wong Photo 46

Accounting Tech At Mwd

Position:
accounting tech at MWD
Location:
Greater Los Angeles Area
Industry:
Utilities
Work:
MWD
accounting tech
Lilly Wong Photo 47

Independent Education Management Professional

Location:
United States
Industry:
Education Management

Publications & IP owners

Us Patents

Treatment Of Cancer With Tor Kinase Inhibitors

US Patent:
2013024, Sep 19, 2013
Filed:
Mar 14, 2013
Appl. No.:
13/803061
Inventors:
Kristen Mae Hege - Burlingame CA, US
Heather Raymon - San Diego CA, US
Lilly Loraine Wong - Solana Beach CA, US
Assignee:
SIGNAL PHARMACEUTICALS, LLC - San Diego CA
International Classification:
A61K 31/4985
US Classification:
514249, 435184, 435 15
Abstract:
Provided herein are methods for treating or preventing head and neck squamous cell carcinoma, comprising administering an effective amount of a TOR kinase inhibitor to a patient having head and neck squamous cell carcinoma.

Antiproliferative Compounds And Methods Of Use Thereof

US Patent:
2022028, Sep 8, 2022
Filed:
Nov 8, 2021
Appl. No.:
17/521432
Inventors:
- Summit NJ, US
Gordon L. Bray - San Francisco CA, US
James Carmichael - Nottingham, GB
Soraya Carrancio - San Diego CA, US
Brian E. Cathers - San Diego CA, US
Matthew D. Correa - San Diego CA, US
Joshua Hansen - La Jolla CA, US
Courtney G. Havens - San Diego CA, US
Timothy S. Kercher - Longmont CO, US
Xiaoling Lu - Whippany NJ, US
Hon-Wah Man - Princeton NJ, US
Mark A. Nagy - Encinitas CA, US
Rama K. Narla - San Diego CA, US
Joseph R. Piccotti - Encinitas CA, US
Daniel W. Pierce - Belmont CA, US
Brandon W. Whitefield - San Diego CA, US
Lilly L. Wong - Solana Beach CA, US
Nanfei Zou - Fanwood NJ, US
International Classification:
A61K 31/496
A61P 35/02
A61K 31/573
A61K 38/05
C07D 401/04
A61P 35/00
Abstract:
Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.

Antiproliferative Compounds And Methods Of Use Thereof

US Patent:
2020025, Aug 13, 2020
Filed:
Apr 27, 2020
Appl. No.:
16/859357
Inventors:
- Summit NJ, US
Gordon L. Bray - San Francisco CA, US
James Carmichael - Nottingham, GB
Soraya Carrancio - San Diego CA, US
Brian E. Cathers - San Diego CA, US
Matthew D. Correa - San Diego CA, US
Joshua Hansen - La Jolla CA, US
Courtney G. Havens - San Diego CA, US
Timothy S. Kercher - Longmont CO, US
Xiaoling Lu - Whippany NJ, US
Hon-Wah Man - Princeton NJ, US
Mark A. Nagy - Encinitas CA, US
Rama K. Narla - San Diego CA, US
Joseph R. Piccotti - Encinitas CA, US
Daniel W. Pierce - Belmont CA, US
Brandon W. Whitefield - San Diego CA, US
Lilly L. Wong - Solana Beach CA, US
Nanfei Zou - Fanwood NJ, US
International Classification:
A61K 31/496
A61P 35/00
C07D 401/04
A61K 38/05
A61K 31/573
A61P 35/02
Abstract:
Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.

Antiproliferative Compounds And Methods Of Use Thereof

US Patent:
2019028, Sep 19, 2019
Filed:
Jun 3, 2019
Appl. No.:
16/430189
Inventors:
- Summit NJ, US
Gordon L. Bray - San Francisco CA, US
James Carmichael - Nottingham, GB
Soraya Carrancio - San Diego CA, US
Brian E. Cathers - San Diego CA, US
Matthew D. Correa - San Diego CA, US
Joshua Hansen - La Jolla CA, US
Courtney G. Havens - San Diego CA, US
Timothy S. Kercher - San Diego CA, US
Xiaoling Lu - Whippany NJ, US
Hon-Wah Man - Princeton NJ, US
Mark A. Nagy - Encinitas CA, US
Rama K. Narla - San Diego CA, US
Joseph R. Piccotti - Encinitas CA, US
Daniel W. Pierce - Belmont CA, US
Brandon W. Whitefield - San Diego CA, US
Lilly L. Wong - Solana Beach CA, US
Nanfei Zou - Fanwood NJ, US
International Classification:
A61K 31/496
C07D 401/04
A61K 31/573
A61P 35/02
A61K 38/05
A61P 35/00
Abstract:
Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.

Antiproliferative Compounds And Methods Of Use Thereof

US Patent:
2019000, Jan 10, 2019
Filed:
Jul 9, 2018
Appl. No.:
16/030695
Inventors:
- Summit NJ, US
Gordon L. Bray - San Francisco CA, US
James Carmichael - Nottingham, GB
Soraya Carrancio - San Diego CA, US
Brian E. Cathers - San Diego CA, US
Matthew D. Correa - San Diego CA, US
Joshua Hansen - La Jolla CA, US
Courtney G. Havens - San Diego CA, US
Timothy S. Kercher - San Diego CA, US
Xiaoling Lu - Whippany NJ, US
Hon-Wah Man - Princeton NJ, US
Mark A. Nagy - Encinitas CA, US
Rama K. Narla - San Diego CA, US
Joseph R. Piccotti - Encinitas CA, US
Daniel W. Pierce - Belmont CA, US
Brandon W. Whitefield - San Diego CA, US
Lilly L. Wong - Solana Beach CA, US
Nanfei Zou - Fanwood NJ, US
International Classification:
A61K 31/496
A61P 35/02
Abstract:
Provided herein is 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing or managing multiple myeloma using such compounds. Also provided are pharmaceutical compositions comprising the compounds, and methods of use of the compositions.

Substituted Aminopurine Compounds, Compositions Thereof, And Methods Of Treatment Therewith

US Patent:
2017028, Oct 5, 2017
Filed:
Mar 31, 2017
Appl. No.:
15/475899
Inventors:
- San Diego CA, US
Gordon L. Bray - San Francisco CA, US
Ellen Filvaroff - San Francisco CA, US
Robert Hubbard - San Diego CA, US
David Mikolon - San Diego CA, US
Heather Raymon - San Diego CA, US
Tao Shi - San Diego CA, US
Tam M. Tran - San Diego CA, US
Toshiya Tsuji - San Diego CA, US
Lilly L. Wong - Solana Beach CA, US
Shuichan Xu - San Diego CA, US
Dan Zhu - San Diego CA, US
International Classification:
A61K 31/52
Abstract:
Provided herein are methods for treating or preventing a cancer, including solid tumors and hematological cancers, comprising administering an effective amount of aminopurine compounds of formula (I), and compositions comprising an effective amount of such compounds.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.